[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.172.195.82. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1985

Mitomycin and Fluorouracil With Concomitant Radiotherapy in Head and Neck Cancer

Author Affiliations

Galveston, Tex
From the Department of Otolaryngology—Head and Neck Surgery (Drs Kaplan, Johns, and Cantrell), Division of Therapeutic Radiology and Oncology (Drs Hahn and Constable), and the Division of Hematology and Oncology (Dr Stewart), University of Virginia Medical Center, Charlottesville. Dr Kaplan is currently at the University of California School of Medicine, San Francisco. Dr Johns is currently at The Johns Hopkins Hospitals, Baltimore.

Arch Otolaryngol. 1985;111(4):220-222. doi:10.1001/archotol.1985.00800060044004
Abstract

• Forty-two previously untreated patients with predominantly stage IV (35) head and neck squamous cell carcinoma were treated preoperatively with mitomycin and fluorouracil and concomitant radiotherapy with 5,000 to 6,000 rad using a split-course technique. Toxic reactions were acceptable. Five patients developed severe mucositis. The white blood cell count fell to 1,500/cu mm in two patients; the platelet count fell to 100,000/cu mm in three. Other complications occurred in three patients. Eightysix percent of patients completed advised treatment. Complete response, assessed clinically and with histologic correlation, was 79% at primary sites and 69% at nodal sites. Twenty-seven patients had a complete response (64%). Follow-up currently is between ten and 24 months. Though analysis of disease-free intervals and survival data is premature, the high complete response rates in this study are encouraging.

(Arch Otolaryngol 1985;111:220-222)

×